Advances in the treatment of hemophilia.
Kessler
Craig M
CM
Department of Medicine and Pathology, Division of Hematology/Oncology, Clinical Coagulation Laboratory, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC 20057, USA.
D005164:Factor IX / Q000627:therapeutic use; D005169:Factor VIII / Q000009:adverse effects* / Q000096:biosynthesis* / Q000276:immunology; D006467:Hemophilia A / Q000150:complications / Q000188:drug therapy* / Q000276:immunology; D006801:Humans; D007518:Isoantibodies / Q000276:immunology; D007592:Joint Diseases / Q000517:prevention & control
D007518:Isoantibodies; C078147:F8 protein, human; D005169:Factor VIII; D005164:Factor IX